Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02072265
Other study ID # 201309057RINC
Secondary ID
Status Not yet recruiting
Phase N/A
First received February 12, 2014
Last updated February 24, 2014
Start date March 2014

Study information

Verified date February 2014
Source National Taiwan University Hospital
Contact Po-Yuan Shih, MD
Phone 886-2-23123456
Email b87401084@ntu.edu.tw
Is FDA regulated No
Health authority Taiwan: Ministry of Health and Welfare
Study type Observational

Clinical Trial Summary

Permanently implantable venous ports (Port-A) is very important to patients receiving chemotherapy. It not only provides a reliable route to administrate intravenous drugs, and it also requires minimal care when it is not in use. However, catheter related blood stream infection(CRBSI) is one of the serious complications of Port-A. The diagnosis of CRBSI relies on limited tools, including blood culture or symptoms and signs of active infection. In the stage of CRBSI, Port-A removal is necessary and pose the risk for the patients to re-implant the Port-A. Thus, it is crucial to early detect the infection and give appropriate treatment. Among the pathogens, some pathogens are related to skin contaminants. Before systemic spreading, these pathogens may colonize or cause minor infection subcutaneously. This investigation is to utilize a non-invasive dual spectrum infrared imaging system to evaluate the Port-A wound and to detect the infection.

Aim: 1. To build the database of infra-red thermal images of Port-A wound healing. 2. To investigate the thermal images of skin contamination related CRBSI and to compare with the thermal images of the CRBSI of unknown foci


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date
Est. primary completion date November 2014
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria:

- clinical requirement of chemotherapy with Port-A

Exclusion Criteria:

- not able to maintain posture during acquiring the thermal images

- with other wounds over the nearby area of the Port-A wound

- with other severe underlying disease and too weak to mobilize

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Wound Healing Disturbance of Port-A

Intervention

Device:
Infrared thermal images


Locations

Country Name City State
Taiwan National Taiwan University Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Port-A wound healing/infection status (infrared thermal images) The patient will be followed once about 1 day before stitches removal of the port-A wound. No
Primary Port-A wound healing/infection status (infrared thermal images) The patient will be followed once about 6 to 24 hours before the first chemotherapy No
Primary Port-A wound healing/infection status (infrared thermal images) The patient will be followed once about 6 to 24 hours before the second chemotherapy No
Primary Port-A wound healing/infection status (infrared thermal images) The patient will be followed once about 1 day before Port-A removal due to infection No